We studied lung collagen metabolism in 18 patients with hypersensitivity pneumonitis to determine if changes at this level could explain the different clinical courses followed by these patients. Collagen concentration, biosynthesis and degradation were measured in lung tissue samples obtained before treatment. Four patients healed, eight improved and six did not improve or worsened. All patients who healed showed an important increase in collagenolysis;
Hypersensitivity pneumonitis (HP) represents a group oflung diseases provoked by the inhalation of a variety of organic particles and characterized by a diffuse and predominantly mononuclear inflammation of the lower respiratory tract. 2 Although the mechanisms involved in its pathogenesis are not completely understood, most authors agree that this disorder is triggered by a complex sequence of events, mainly mediated by a T-cell hyperreactivity [1] [2] [3] Once considered a benign disease, that is, easily reversible by avoiding the etiologic agent and applying steroid therapy, it has currently become evident that some patients may follow a chronic course and continue to be symptomatic in spite of treatment. Moreover, some of them may evolve progressively to interstitial lung fibrosis. [4] [5] [6] Unfortunately, almost all the experimental and human studies have been focused on the pulmonary damage mechanisms, both immunologic and nonimmunologic, [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] but few attempts have been made to determine why some patients heal, others remain with clinical and/or functional abnormalities and still others progress to fibrosis. Obviously the clinical course of the disease may depend on a complex series of interrelated factors such as genetic predisposition, intensity and duration of exposure, evolution time before the onset of therapy5"3 but other mechanisms may play a role. Disturbances in the appropriate patients who improved had normal or high values, but significantly less than those obtained in patients who healed. Finally, five out of the six patients who did not improve or worsened had a significant decrease in degradation. These findings support the notion that a diminution of local collagenolysis may play a role in the progression to fibrosis in some patients with hypersensitivity pneumonitis and can also be a useful tool to predict the prognosis of this disease.
control of collagen metabolism may be one of them.
In this context, we currently know that lung collagen turnover is an active and dynamic process, and changes in either synthesis or degradation could play an important role in the regulation of the deposit and amount of interstitial collagens in different lung diseases. 14 Thus, we have recently demonstrated that patients with idiopathic pulmonary fibrosis (IPF) present a noteworthy decrease in the lung collagenolytic activity without an increase in collagen biosynthesis. 5 However, these patients were studied in an advanced stage of this disorder when there was a clear predominance of the fibrosis over inflammation.
On the other hand, Laurent and McAnulty'6 have reported a bleomycin-induced pulmonary fibrosis in rabbits that changes in anabolism and catabolism of this protein are early events in the development of fibrosis. Six days after drug administration, there was a significant increase in collagen synthesis and a decrease in the degradation of newly synthesized collagen. Similar results have been reported in other animal models of interstitial lung diseases (ILD). 17 An indirect proof that a disarrangement of collagen turnover may play a role in the development offibrosis in human ILD, including HP, is the finding by Anttinen et The average duration of symptoms at the time of lung biopsy ranged from three months to three years, with a mean of 13.6 ± 12.6 months. Since in all patients breathlessness preceded the medical consultation, the onset of this symptom was taken as evidence for the clinical initiation of the disease.
Control Subjects
Seven control subjects (five women and two men) were selected from among a group of individuals who had lobectomy or wedge resection for removal of a primary lung tumor, but without any clinical, radiographic or functional evidence of ILD. Moreover, no histologic evidence of disease was found in the lung tissue specimen used for biochemical analyses. The ages of the control subjects ranged from 22 to 58 years, with a mean age of 39.4 ± 12.2 years ( Table 1) .
Handling of Tissue Samples
Immediately after the biopsy, lung specimens were divided into four portions. One portion was fixed with buffered 10 percent formaldehyde and afterward treated according to the conventional techniques for light microscopy. The other three portions were used for the biochemical analyses.
Collagen Concentration Lung samples of about 100 mg (wet) were dried to constant weight, and three aliquots were hydrolyzed with 6N hydrochloride (HCI) for 24 hours at 100°C, filtered, dried, and resuspended in distilled water. Subsequently, hydroxyproline content was measured by a colorimetric assay. 20 The amount of collagen in each aliquot was calculated by multiplying hydroxyproline content x 7.23, on the assumption that this residue constitutes about 14 percent of the total amount of amino acids in the alpha chain. Collagen concentration was expressed as milligrams per gram of dry weight.
Collagen Biosynthesis Assay
The method used is described elsewhere." Briefly, lung samples were divided in three portions weighing about 75 to 100 mg (wet). These samples were incubated separately in 4 ml of Dulbecco's modified Eagle's medium containing 10 percent fetal calf serum, 50 p.g/ml ascorbic acid, 70 pLg/ml ferrous sulfate (the last two reagents were used as cofactors of proline hydroxylase), 200 U/ml penicillin, and 200 j±g/ml streptomycin.
The cultures were equilibrated with 95 percent oxygen/5 percent carbon dioxide and incubated at 37°C in a shaking water bath. After one hour, the medium was replaced with 4 ml of fresh culture medium with the above constituents and also containing 30 1±Ci of 32 .2 Ci/mmol, New England Nuclear, Boston, MA). Afterward, the cultures were incubated for four hours. At the end of the incubation period, the tissue samples were homogenized with a polytron tissue homogenizer (Brinkman Instruments, Westbury, NY) in 10 percent trichloroacetic acid (TCA), and washed three more times with 5 percent TCA. The TCA precipitable material was hydrolized for 24 h in 6N HCI at 100°C, filtered, evaporated, and dissolved in 2 ml of distilled water. The 3H-hydroxyproline was separated according to the method of Rojkind and Gonzalez2" and counted in a beta scintillation counter (Beckman LS-IOOC). The results were expressed as counts per minute of 3H-hydroxyproline per milligram of incubated tissue per hour.
Collagen Degradation Assay
We used a modification of the method by Ryan and Woessner.i
Lung tissue samples of about 500 mg (wet) were homogenized and divided into six aliquots. Three of them were incubated in a metabolic shaker for 24 h at 37°C in the presence of 5.0 mM calcium dichloride, 0.15M sodium chloride, and 0.04M tris buffer pH 7.4. The remaining three aliquots were incubated under the same conditions but 0.4M ethylenediaminetetraacetate (EDTA [collagenase inhibitor]) was added. Only EDTA-inhibitable degradation was considered as specific collagenolytic activity.
With the purpose of measuring only degraded collagen, the homogenates were centrifuged at 4°C for 30 min at 21,000 g, and the supernatant was filtered through a membrane with an exclusion limit of 100,000 daltons (Diaflo XM-100, Amicon Corporation, Lexington, MA). Thus, the fragments obtained were smaller than an alpha chain of collagen. Digestion was detected by the release of soluble hydroxyproline-containing material.
With the aim of controlling the ratio ofactive enzyme to substrate, the collagen content was quantified separately in each aliquot of the homogenate, and the collagenolytic activity was expressed as micrograms of collagen degraded per milligram of collagen incubated per hour. This assay measures collagen degradation as a whole, and no attempt was made to establish which particular collagen (type 1, type 3 or another) was more or less affected.
Follow-Up
Two weeks after the lung biopsy the patients were conventionally treated with prednisone and then followed-up between one to three years. Prednisone was administered at a dose of 1 mg/kg for one month, followed by a gradual reduction of about 5 mg of the total dose each three or four weeks, until a maintenance dose of 10 to 15 mg/day was reached. If a patient was considered to be healed, this dose was sustained for another month, and then suspended. The patients who showed an objective improvement but did not heal continued with the maintenance dose. In the case of the patients who worsened, prednisone was newly increased, and maintained at 20 to 30 mg/day during the complete course of this study.
After the last study patients were classified in three groups according to their clinical, radiologic and functional findings, as follows. Group 1 (n=4): Healed, when there was complete disapLung Collagen Metabolism and Hypersensitivity Pneumonitis (Selman et al) pearance of dyspnea, and the functional respiratory tests and thorax x-ray film had reached normality Group 2 (n = 8): Improved, when there was an objective and subjective amelioration of dyspnea, an increase ofat least 15 (Tables 2 and 3) in spite ofvery similar severity in dyspnea and gas exchange abnormalities (arterial oxygen pressure at rest of 34, 44 and 40 mm Hg, respectively). Table 1 summarizes the individual data obtained from control subjects, and Tables 2 and 3 show the patients' ages, the evolution time of the disease prior to the biopsy, the biochemical results and their relationship with the clinical course after one to three years offollow-up. The patients were separated according to their response to treatment into the three groups previously mentioned.
The four patients who healed had a mean age of 26 ± 7.8 years, which was significantly lower than the average age of the other two groups (p<0.05). In contrast, the evolution time of the disease before biopsy and the onset of therapy did not seem to influence the prognosis. In this sense, the four patients who healed and five ofsix patients who did not improve or who worsened showed an onset of the clinical disease of 12 months or less.
In relationship to the biochemical analyses, three patients (Nos. 13, 14 and 16) showed a slight increase of collagen concentration, which coincided with the morphologic observations of the lung. One degradation. On the other hand, only one case of the pression of both parameters and formulated a metasix who showed no improvement or worsened prebolic index (synthesis/degradation). In this context, we sented an increase of collagen synthesis, and in this found that whereas the average of control subjects was patient collagenolysis was lower.
1.0, group 1 showed a decrease in this index with an In comparison with biosynthesis, a different picture average of 0.5. On the other hand, group 2 presented emerged from the analysis ofthe collagenolytic activity an increase of this ratio with a mean of 1.49, due to (Tables 2 and 3 and Fig 1) . In this context, there were an elevation of collagen production. Finally group 3 noteworthy differences between the three groups.
showed the highest metabolic index, with an average Thus, all of the patients who healed showed a severalof 2.17; however, the increase in this case was due to fold increase of collagenolysis, with an average of a decrement in collagenolytic activity 0.877 ± 0.16 ,ug of collagen degraded per milligram of When we applied the ROC curve to analyze the collagen incubated per hour (p<0.001 in relation to sensitivity specificity efficiency and predictive values the control subjects). Patients who improved showed of collagen degradation in relation to the prognosis, normal or high values, and their average was of we observed that when the collagenolytic activity is 0.431±0.242, which is higher than that in control higher than 0.6, the positive predictive value for subjects but significantly lower than the mean obtained healing is 80 percent. In contrast, when it is less than for patients who healed (p<0. 05). In contrast, five out 0. 15 the positive predictive value for not improving or of six patients who did not show improvement or worsening is 100 percent. worsened presented a decrease in collagenolytic activity of approximately one half to normal values DISCUSSION (p<0. 001).
One ofthe most intriguing and less studied questions In order to obtain a ratio between collagen synthesis concerning HP is why regardless of the type and time and collagen degradation, we made uniform the exof exposure to an organic particle, the avoidance of Undoubtedly numerous factors may operate in this process, and we believe that one of them can be an abnormal turnover of collagen. In this sense, the studies regarding this problem are recent and little is known about the rates of collagen metabolism in normal human lungs. Different studies have demonstrated that, at least in animal models, collagen synthesis and degradation are very dynamic processes;'6"17 thus, some changes in either anabolism or catabolism could potentially play a major role in the regulation of collagen mass in pulmonary diseases. 14 Our study which to our knowledge is the first in this field in patients with HP, was designed to determine if some modifications in collagen metabolism occur in this disease, and if so, how these influence the clinical course of the patients. Our results showed that 44 percent of the cases had increased collagen synthesis. However, this alteration by itself did not seem to contribute to the prognosis since most of them healed or improved. This finding may correlate with the results of Kirk et a123 who reported that in pulmonary fibrosis there is an initial increase of type 3 collagen production, which occurs in lung areas of active fibrosis, but this phase of fibrogenesis may be reversible. In fact, patients with the highest concentrations ofserum type 3 procollagen peptide, that is, highest type 3 collagen synthesis, showed a better response to steroid treatment.
On the other hand, the increment of collagen biosynthesis in some of our patients may be due, at least in part, to the production of platelet-derived growth factor, which we have previously found in interstitial and intra-alveolar macrophages in about 30 percent of patients with HP24 However, the most relevant finding of this study was related to the endogenous collagenolytic-activity In this context, there was a clear difference between patients who healed or improved and those who did not improve or worsened. Thus, whereas the former presented elevated rates of collagenolysis, the latter showed a noteworthy decrease in collagen breakdown. In this sense, we can hypothesize that an increase in local collagenolysis is a defensive mechanism to avoid excessive accumulation of collagen, and in this way, the development of fibrosis.
Interestingly, a better response was also seen in younger patients, similar to the finding by TurnerWarwick et a125 in IPF, but the age of patients and control subjects did not show a direct relationship to lung collagenolysis results.
Our findings related to collagenolytic activity in HP agree with those reported for IPF15 in which all patients with fibrotic predominance showed decreased collagen degradation, and the same has been demonstrated in other fibrotic organs.26'27 Moreover, a decrease in collagenolysis seems to be an early phenomenon in experimental lung fibrosis. '6 Nevertheless, other authors28'29 have suggested that collagenase may play a role in the development, and not in the arrest of reversal, of the fibrotic process in some ILD. However, these studies have several potential methodologic drawbacks, for example, the use of bronchoalveolar lavage (BAL) as a source of collagenase, and soluble radioactively labelled collagen produced in vitro as substrate. In our opinion, this type of assay does not resemble the events occurring in the lung microenvironment, where collagen in the extracellular space exists in an insoluble form and in a complex state of aggregation with other interstitial macromolecules, and therefore, is probably less susceptible to the action of the enzyme. In this sense, our assay is a closer approach to the parenchymal situation.
In support of this point of view, Christner et al,30 using a similar technique to the studies mentioned before, also have found collagenase activity in BAL of patients with adult respiratory distress syndrome (ARDS), which may evolve to fibrosis,3' but this finding seemed associated with the lung inflammatory response rather than with the development of fibrosis. Thus, the enzyme was present both in ARDS survivors and nonsurvivors, and the authors postulate that the increase in degradation may be necessary in order to return the lung to its baseline physiologic state.
On the other hand, our findings may be interpreted from two interrelated points of view One of them is the role of the triggering of modifications in collagen turnover regarding the progression of HP to fibrosis.
In this study no histologic evidence was obtained to prove that the patients who did not improve or worsened developed interstitial lung fibrosis because, for ethical reasons, a second biopsy was not performed. Since lung biopsy is usually performed before treatment, the measurement ofthis biochemical parameter, along with others such as procollagen type 3 peptide,23 may allow clinicians to have a better approach to prognosis. Perhaps in the future these patients may be treated with some of the antifibrotic drugs currently under study24 besides steroids.
